You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 11, March 16, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Women's Health, Other
 •Venous Thromboembolism
 •Alert me on articles by topic

Estrogen Plus Progestin and Risk of Venous Thrombosis

Since this article does not have an abstract, we have provided the first 102 words of the full text and any section headings.

To The Editor: The study by Dr Cushman and colleagues1 is based on data from the WHI and details of the methods are reported in an earlier JAMA publication.2 The prior study notes that of the 8506 participants in the CEE + MPA group, 3444 (40.5%) were unblinded for control of vaginal bleeding. Further, CEE and/or MPA doses could have been altered for treatment of this condition, yet no published data from this trial have indicated the effect that this treatment had on the study outcomes. It seems inaccurate to label this a blinded controlled trial of placebo against CEE + MPA.

Richard E. Blackwell, PhD, MD
rblackwe@uabmc.edu
Department of Obstetrics and Gynecology
Division of Reproductive Endocrine and Infertility
University of Alabama
Birmingham

1. Cushman M, Kuller LH, Prentice R, et al, Women's Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004;292:1573-1580. FREE FULL TEXT
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results of the Women's Health Initiative Randomized Controlled Trial. JAMA. 2002;288:321-333. FREE FULL TEXT

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2005;293:1322.


RELATED ARTICLES

Estrogen Plus Progestin and Risk of Venous Thrombosis
Pierre-Yves Scarabin, Emmanuel Oger, Tabassome Simon, and Geneviève Plu-Bureau
JAMA. 2005;293(11):1322.
EXTRACT | FULL TEXT  

Estrogen Plus Progestin and Risk of Venous Thrombosis—Reply
Mary Cushman, Ross Prentice, Bruce M. Psaty, Frits R. Rosendaal, and for the WHI Investigators
JAMA. 2005;293(11):1322-1323.
EXTRACT | FULL TEXT  

Estrogen Plus Progestin and Risk of Venous Thrombosis
Mary Cushman, Lewis H. Kuller, Ross Prentice, Rebecca J. Rodabough, Bruce M. Psaty, Randall S. Stafford, Steven Sidney, Frits R. Rosendaal, and for the Women’s Health Initiative Investigators
JAMA. 2004;292(13):1573-1580.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.